(3-(Difluoromethoxy)-5-fluorophenyl)boronic acid, 98%, 1g

2-Fluorophenyl isopropylcarbamate, 97%, 1g

2-chloro-4-fluoro-4'-morpholinomethyl benzophenone, 97.0%, 1g

6-acetyl-7-hydroxy-4-methyl-2H-chromen-2-one, 100mg

Methyl 2-oxopiperidine-4-carboxylate, 95.0%, 100g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 100mL, >=99%, for peptide synthesis

2-(Benzylamino)-3-trifluoromethylpyridine, 95.0%, 1g

4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol, 95.0%, 250mg

5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride, 97.0%, 1g

2-Methyl-4-(trifluoromethyl)phenylboronic acid, 95.0%, 10g

2-(Trifluoroacetoxy)pyridine, 5g

(S)-1-Cbz-3-Aminopyrrolidine hydrochloride, 97%, 100g

4,5,6,7-Tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine hydrochloride, 95.0%, 500mg